Skip to content

Rapid, opt-out HIV testing accepted by over 99% of women in an urban Malawi program

Interaction between efavirenz and phenytoin can result in undetectable blood levels of efavirenz

Effects of adherence support programmes may be short lived

Injection drug use, low baseline CD4 counts continue to predict poorer HAART response after six years

Managing meningitis in people with HIV in resource-limited settings: a clinical review

Atazanavir pharmacokinetics not appreciably altered during late-stage pregnancy

Existing metabolic syndrome predicts cardiovascular disease and diabetes in HIV-positive people starting anti-HIV treatment

Drug level monitoring nearly doubles likelihood of reaching target levels

Consequences of non-adherence worse in African-Americans than white people